Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Fuller

Showing results (291-300 of 539) with videos related to

Pageof 54
Sort By:
Pharmacological Research Communications|March 1, 1978
Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brainR W Fuller, H D Snoddy, B B Molloy
Pharmacological Research Communications|March 1, 1981
Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated ratsR W Fuller, H D Snoddy, J A Clemens
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1982
Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanismsR A Hahn, M D Hynes, R W Fuller
The Journal of Pharmacy and Pharmacology|January 1, 1979
Modification by harmaline of the effects of N-cyclopropyl-p-chloro-amphetamine on 5-hydroxyindole concentration in rat brainR W Fuller, S K Hemrick, K W Perry
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067)M L Cohen, C J Parli, R W Fuller
Psychopharmacology Communications|January 1, 1975
Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitorsR W Fuller, H D Snoddy, B B Molloy
European Journal of Pharmacology|August 1, 1975
Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamineR W Fuller, K W Perry, B B Molloy
Annals of the New York Academy of Sciences|May 11, 1992
MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administrationM G Henderson, S Hemrick-Luecke, R W Fuller
Neuropharmacology|May 1, 1984
Interactions of trazodone with serotonin neurons and receptorsR W Fuller, H D Snoddy, M L Cohen
The Journal of Pharmacy and Pharmacology|January 1, 1981
Antagonism by (--)-methadone of the depletion of 5-hydroxytryptamine in rat brain by p-chloroamphetamineR W Fuller, K W Perry, M D Hynes
Pageof 54

Showing results (291-300 of 539) with videos related to

Sort By:
Pageof 54
Pharmacological Research Communications|March 1, 1978
Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brainR W Fuller, H D Snoddy, B B Molloy
Pharmacological Research Communications|March 1, 1981
Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated ratsR W Fuller, H D Snoddy, J A Clemens
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1982
Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanismsR A Hahn, M D Hynes, R W Fuller
The Journal of Pharmacy and Pharmacology|January 1, 1979
Modification by harmaline of the effects of N-cyclopropyl-p-chloro-amphetamine on 5-hydroxyindole concentration in rat brainR W Fuller, S K Hemrick, K W Perry
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067)M L Cohen, C J Parli, R W Fuller
Psychopharmacology Communications|January 1, 1975
Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitorsR W Fuller, H D Snoddy, B B Molloy
European Journal of Pharmacology|August 1, 1975
Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamineR W Fuller, K W Perry, B B Molloy
Annals of the New York Academy of Sciences|May 11, 1992
MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administrationM G Henderson, S Hemrick-Luecke, R W Fuller
Neuropharmacology|May 1, 1984
Interactions of trazodone with serotonin neurons and receptorsR W Fuller, H D Snoddy, M L Cohen
The Journal of Pharmacy and Pharmacology|January 1, 1981
Antagonism by (--)-methadone of the depletion of 5-hydroxytryptamine in rat brain by p-chloroamphetamineR W Fuller, K W Perry, M D Hynes
Pageof 54